Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275)

In our institution, a prospective observational trial testing micro-RNA (miRNA) and ARV7 mutational status in metastatic, castration resistant prostate cancer (mCRPC), is currently recruiting (PRIMERA trial, NCT04188275). A pre-planned interim analysis was performed when 50% of the planned accrual w...

Descripción completa

Detalles Bibliográficos
Autores principales: Francolini, G., Loi, M., Salvestrini, V., Mangoni, M., Detti, B., Di Cataldo, V., Aquilano, M., Pinzani, P., Salvianti, F., Desideri, I., Mariotti, M., Garlatti, P., Stocchi, G., Ciccone, L. P., Lucidi, S., Salvatore, G., Sottili, M., Meattini, I., Livi, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Clinical & Translational Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510932/
https://www.ncbi.nlm.nih.gov/pubmed/34410545
http://dx.doi.org/10.1007/s10585-021-10118-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510932/
https://www.ncbi.nlm.nih.gov/pubmed/34410545
http://dx.doi.org/10.1007/s10585-021-10118-7

Ejemplares similares